Abstract
Background: Uterine fibroids are common benign tumors among premenopausal women. High- intensity focused ultrasound (HIFU) is an emerging non-invasive intervention which uses the high-intensity ultrasound waves from ultrasound probes to focus on the targeted fibroids. However, the efficacy of HIFU in comparison with that of other common treatment types in clinical procedure remains unclear.Objective: To investigate the comparative effectiveness and safety of HIFU with other techniques which have been widely used in clinical settings.Methods: We searched the Cochrane Central Register of Controlled Trials, PubMed, EMBASE, Cumulative Index to Nursing & Allied Health Literature, Web of Science, ProQuest Nursing & Allied Health Database, and three Chinese academic databases, including randomized controlled trials (RCTs), non-RCTs, and cohort studies. The primary outcome was the rate of re-intervention, and the GRADE approach was used to interpret the findings.Results: About 18 studies met the inclusion criteria. HIFU was associated with an increased risk of re-intervention rate in comparison with myomectomy (MYO) [pooled odds ratio (OR): 4.05, 95% confidence interval (CI): 1.82–8.9]. The results favored HIFU in comparison with hysterectomy (HYS) on the change of follicle-stimulating hormone [pooled mean difference (MD): −7.95, 95% CI: −8.92–6.98), luteinizing hormone (MD: −4.38, 95% CI: −5.17−3.59), and estradiol (pooled MD: 43.82, 95% CI: 36.92–50.72)]. HIFU had a shorter duration of hospital stay in comparison with MYO (pooled MD: −4.70, 95% CI: −7.46−1.94, p < 0.01). It had a lower incidence of fever (pooled OR: 0.15, 95% CI: 0.06–0.39, p < 0.01) and a lower incidence of major adverse events (pooled OR: 0.04, 95% CI: 0.00–0.30, p < 0.01) in comparison with HYS.Conclusions: High-intensity focused ultrasound may help maintain feminity and shorten the duration of hospital stay. High-quality clinical studies with a large sample size, a long-term follow-up, and the newest HIFU treatment protocol for evaluating the re-intervention rate are suggested to be carried out. Clinical decision should be based on the specific situation of the patients and individual values.
Highlights
Uterine fibroids are common benign tumors which are rich in extracellular matrix among premenopausal women [1, 2]
In Barnard et al [19], only the cohort data were included in the meta-analysis
Data from this study did not find any statistically significant differences between these two techniques for follicle-stimulating hormone (FSH) (MD: −0.20, 95% confidence interval (CI): −0.91–0.51, p = 0.58), luteinizing hormone (LH) (MD: 0.10, 95% CI: −0.55–0.75, p = 0.76), and E2 (MD: −1.00, 95% CI: −7.42–5.42, p = 0.76) (Supplementary Figures 4–6)
Summary
Uterine fibroids are common benign tumors which are rich in extracellular matrix among premenopausal women [1, 2]. Fibroids can cause severe menstrual bleeding and menorrhagia, which may lead to iron deficiency anemia. The conventional surgical approaches to fibroid treatment comprise hysterectomy (HYS) or abdominal myomectomy (MYO) for those desiring uterine preservation. Invasive techniques for the treatment of uterine fibroids have been developed in recent years, such as high-intensity focused ultrasound (HIFU), laparoscopic MYO, uterine artery embolization (UAE), and radiofrequency ablation (RFA) [5,6,7]. Uterine fibroids are common benign tumors among premenopausal women. High- intensity focused ultrasound (HIFU) is an emerging non-invasive intervention which uses the high-intensity ultrasound waves from ultrasound probes to focus on the targeted fibroids. The efficacy of HIFU in comparison with that of other common treatment types in clinical procedure remains unclear
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
